BioAgilytix Revenue and Competitors

Claim your profile

Location

$30.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioAgilytix's estimated annual revenue is currently $242.3M per year.(i)
  • BioAgilytix received $Undisclosed in venture funding in June 2013.
  • BioAgilytix's estimated revenue per employee is $248,000
  • BioAgilytix's total funding is $30.1M.

Employee Data

  • BioAgilytix has 977 Employees.(i)
  • BioAgilytix grew their employee count by 21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31800M1098004%$367M$146B

BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina's Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP. BioAgilytix's team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 23 of the top 25 global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

$30.1M

Total Funding

977

Number of Employees

$242.3M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioAgilytix News

2022-03-30 - Global Arbovirus Testing Market Research Report 2022-2026: Increasing Number of M&A and the Growing Presence of OEMs - ResearchAndMarkets.com

KG, ARUP Laboratories, BioAgilytix Labs, Copley Scientific Ltd., Distek Inc., Fluke Biomedical, Mayo Foundation for Medical Education and...

2021-10-14 - BioAgilytix : Closes Acquisition of Australia-based 360biolabs®

Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stages DURHAM, N.C., Oct. 14, 2021 ...

2021-08-18 - MicroConstants to Join BioAgilytix Family USA - English España - español

DURHAM, N.C., Aug. 18, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive agreement t ...

2021-08-18 - MicroConstants Signs Agreement to Join BioAgilytix Family, to be Known as BioAgilytix San Diego

SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- MicroConstants, Inc., a leader in bioanalytical testing services, announced that it has signed an agreement with BioAgilytix Labs, a leading global contract research organization (CRO) focused on supporting its pharmaceutical and biotech partners in all ...

2019-08-20 - Orasure Technologies Appoints James a. Datin to Its Board of Directors

Mr. Datin, age 56, currently serves as the President and Chief Executive Officer of BioAgilytix, LLC, a global bioanalytical contract research ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$207.7M989-1%N/A
#2
$269.1M106817%N/A
#3
$216.7M1078-3%N/A
#4
$156.4M10953%N/A
#5
$253.8M11123%N/A

BioAgilytix Funding

DateAmountRoundLead InvestorsReference
2013-06-05$UndisclosedUndisclosedRiverside PartnersArticle